Amedisys, Inc. (AMED)
NASDAQ: AMED · IEX Real-Time Price · USD
91.16
-0.08 (-0.09%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Amedisys Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Amedisys stock have an average target of 99.5, with a low estimate of 88 and a high estimate of 103. The average target predicts an increase of 9.15% from the current stock price of 91.16.
Analyst Consensus: Hold
* Price targets were last updated on Mar 25, 2024.
Analyst Ratings
The average analyst rating for Amedisys stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Buy | 4 | 4 | 4 | 4 | 1 | 1 |
| Hold | 10 | 10 | 10 | 10 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 26, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $97 → $100 | Buy | Maintains | $97 → $100 | +9.70% | Mar 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $100 → $101 | Hold | Maintains | $100 → $101 | +10.79% | Sep 14, 2023 |
| TD Cowen | TD Cowen | Hold Maintains $84 → $101 | Hold | Maintains | $84 → $101 | +10.79% | Jul 31, 2023 |
| Credit Suisse | Credit Suisse | Hold Reiterates $101 | Hold | Reiterates | $101 | +10.79% | Jul 27, 2023 |
Financial Forecast
Revenue This Year
2.37B
from 2.24B
Increased by 5.80%
Revenue Next Year
2.51B
from 2.37B
Increased by 5.87%
EPS This Year
4.66
from -0.30
EPS Next Year
5.11
from 4.66
Increased by 9.67%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.5B | 2.7B | 2.8B |
| Avg | 2.4B | 2.5B | 2.7B |
| Low | 2.2B | 2.3B | 2.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.8% | 13.2% | 10.1% |
| Avg | 5.8% | 5.9% | 6.9% |
| Low | 0.4% | -1.8% | 2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.06 | 6.02 | 4.76 |
| Avg | 4.66 | 5.11 | 4.62 |
| Low | 4.26 | 4.41 | 4.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 29.2% | -6.8% |
| Avg | - | 9.7% | -9.5% |
| Low | - | -5.3% | -13.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.